BeiGene (06160) appointed Wang Lai, the company's head of global R&D, as the company's president and head of global R&D

Zhitongcaijing · 3d ago

According to Zhitong Finance App, BeiGene (06160) issued an announcement. On December 17, 2025, after review and approval by the board of directors of BeiGene Co., Ltd. (hereinafter referred to as the “Company”), the board of directors of the company agreed to appoint Dr. Wang Lai, head of the company's global R&D, as the company's president and head of global R&D. After the appointment became effective, Dr. Wang Lai served as the company's president and head of global R&D, and was responsible for managing the company's R&D, business development, and business alliance management functions.